Kerato - How are corneal transplants advancing in the field of ophthalmology?15 Oct 2024 11:11
Sarah Greenhalgh, co-founder and managing director of Kerato Ltd, a wholly owned subsidiary of BSFA plc to commercialise its expertise in biomimetic tissue engineering, has written an article on how private business and university research combining world-leading expertise in tissue engineering and corneal physiology to advance the development of a novel treatment for the repair of corneal damage and perforation.
Read more here > https://www.pharmafocus.com/articles/looking-ahead-the-future-of-corneal-transplants